Macroeconomic Consequences of Type 1 Diabetes: Productivity Loss and Healthcare Expenditure
Keywords:
Type 1 diabetes, Productivity Loss, Healthcare expenditure, Economic burdenAbstract
Individuals with T1D carry the economic burden of the illness itself as well as its treatment, along with the burden on healthcare systems and the economy. In this study, we consider the macroeconomic consequences of T1D in India at the productivity loss and healthcare expenditure. In order to quantify these direct and indirect costs of T1, we use data from global and national health surveys, economic studies and healthcare databases to analyse trends from 2000 to 2045. We found that T1D is becoming increasingly common, and that the number of affected people is predicted to exceed 124.9 million by 2045 and that these costs will be substantial for healthcare and productivity. The economic impact is estimated to increase directly to USD 8.5 billion in 2021 while incrementally to USD 12.8 billion by 2045 while the indirect cost that includes absenteeism, presenteeism and mortality before active age contribute to magnify. Complications like neuropathy, retinopathy, coronary artery disease also play a major role in the disease burden. The study stresses the constraints of macroeconomic consequences of T1D in India through improved access to insulin and early diagnosis and workplace accommodations. This increasing public health challenge requires policymakers to enforce cost effective strategies to tackle this challenge and to minimise the economic burden on the individuals and on the health care system.
Downloads
References
AIIMS Delhi. (2023). Pediatric Diabetes Clinic Annual Report. https://aiims.edu
American Diabetes Association (ADA). (2020). Economic costs of diabetes in the U.S. Diabetes Care, 43(5), 917–932. https://doi.org/10.2337/dci20-0007
Anjana, R. M., Deepa, M., Pradeepa, R., Mahanta, J., Narain, K., Das, H. K., ... & Mohan, V. (2017). Prevalence of diabetes and prediabetes in India: Results from the ICMR-INDIAB study. The Lancet Diabetes & Endocrinology, 5(8), 585–596. https://doi.org/10.1016/S2213-8587(17)30174-2
Anjana, R. M., et al. (2021). Glycemic control in young people with Type 1 diabetes in India: Challenges and solutions. Indian Journal of Endocrinology and Metabolism, 25(3), 184–191. https://doi.org/10.4103/ijem.ijem_220_21
Basu, S., Yudkin, J. S., Sussman, J. B., Millett, C., & Hayward, R. A. (2019). Alternative strategies to achieve equitable diabetes prevention and care in high-income countries: A microsimulation study. The Lancet Diabetes & Endocrinology, 7(9), 705–715. https://doi.org/10.1016/S2213-8587(19)30197-0
BeatO. (2023). Impact Assessment in Karnataka. https://beatO.in
Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Davies, J. I. (2017). The global economic burden of diabetes in adults aged 20–79 years: A cost-of-illness study. The Lancet Diabetes & Endocrinology, 5(6), 423–430. https://doi.org/10.1016/S2213-8587(17)30097-9
Bommer, C., Sagalova, V., Heesemann, E., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Davies, J. I. (2018). Global economic burden of diabetes in adults: Projections from 2015 to 2030. Diabetes Care, 41(5), 963–970. https://doi.org/10.2337/dc17-1962
Chen, R., Oviedo-Orta, E., Mukherjee, M., Pollack, M. F., & Ueda, K. (2022). Economic burden of type 1 diabetes: A systematic review. Diabetes Therapy, 13(4), 761–779. https://doi.org/10.1007/s13300-022-01213-8
Delhi Government. (2021). Mohalla Clinics: Performance Audit. https://health.delhi.gov.in
Hex, N., Bartlett, C., Wright, D., Taylor, M., & Varley, D. (2012). Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Medicine, 29(7), 855–862. https://doi.org/10.1111/j.1464-5491.2012.03698.x
Indian Council of Medical Research (ICMR). (2020). Economic Burden of Diabetes in India.
International Diabetes Federation (IDF). (2021). IDF Diabetes Atlas, 10th Edition. Brussels, Belgium: IDF. https://www.diabetesatlas.org
International Diabetes Federation (IDF). (2021). IDF Diabetes Atlas, 10th Edition.
International Diabetes Federation. (2021). IDF Diabetes Atlas (10th ed.). https://diabetesatlas.org/
Karnataka Health Dept. (2022). Draft Insulin Mission Policy. https://karhealth.karnataka.gov.in
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berkovic, M., Enters-Weijnen, C., Forsén, T., ... & Peyrot, M. (2019). Rates and predictors of hypoglycaemia in 27 countries with Type
1 diabetes: Results from the Global HAT observational study. Diabetes, Obesity and Metabolism, 21(1), 119–127. https://doi.org/10.1111/dom.13432
Kumar, K. M. P. (2020). "Tamil Nadu’s Diabetes Registry: A Model for India." Indian Journal of Endocrinology, 24(3), 45-51. https://doi.org/10.4103/ijem.IJEM_220_20
Kumar, K. M. P., et al. (2021). Insulin access and affordability in South Asia: A comparative analysis. Diabetes Research and Clinical Practice, 172, 108634. https://doi.org/10.1016/j.diabres.2021.108634
Life for a Child. (2023). India Program Report. https://lifeforachild.org
Mohan, V., et al. (2020). Financial burden of diabetes care in low-income households in India. The Lancet Global Health, 8(6), e789–e797. https://doi.org/10.1016/S2214-109X(20)30109-5
Mohan, V., Sandeep, S., Deepa, R., Shah, B., & Varghese, C. (2019). Epidemiology of type 2 diabetes in India. Indian Journal of Medical Research, 149(2), 129–136. https://doi.org/10.4103/ijmr.IJMR_1768_18
Mumbai Diabetes Task Force. (2022). Urban Slum Screening Camp Data.
Nair, M. (2021). "Out-of-Pocket Expenditure on T1D in Kerala." Kerala Medical Journal, 15(2), 112-118.
National Health Mission Kerala. (2022). ASHA Diabetes Training Program Evaluation. https://keralahealth.gov.in
Palmer, A. J., Roze, S., Valentine, W. J., Spinas, G. A., & Lammert, M. (2004). The long‐term cost‐effectiveness of improving glycemic control in Type 1 diabetes mellitus: An analysis based on the Diabetes Control and Complications Trial. Diabetic Medicine, 21(6), 607–614. https://doi.org/10.1111/j.1464-5491.2004.01192.x
Peters, A. L., Garg, S. K., & Freeman, J. V. (2020). Diabetes technology—Continuous glucose monitoring and automated insulin delivery: Benefits, challenges, and recommendations. JAMA, 323(5), 397–398. https://doi.org/10.1001/jama.2019.20669
Project Samridhi Report. (2023). Lilly India CSR Initiative. https://www.lillyindia.com/samridhi
Ramachandran, A., et al. (2020). Cultural barriers to effective diabetes management in South Asia. Journal of Diabetes, 12(5), 343–351. https://doi.org/10.1111/1753-0407.13012
Ramachandran, A., Snehalatha, C., & Shetty, A. S. (2010). Diabetes in Asia: The epidemiology, risk factors, and prevention. Journal of Diabetes, 2(1), 10–17. https://doi.org/10.1111/j.1753-0407.2009.00055.x
Seuring, T., Archangelidi, O., & Suhrcke, M. (2015). The economic costs of Type 2 diabetes: A global systematic review. PharmacoEconomics, 33(8), 811–831. https://doi.org/10.1007/s40273-015-0268-9
Shah, P., et al. (2022). Pediatric Type 1 diabetes in India: Clinical outcomes and economic impact. Pediatric Diabetes, 23(2), 145–153. https://doi.org/10.1111/pedi.13289
Singh, R. (2022). "DKA Mortality in UP/Bihar." Journal of Public Health India, 34(4), 567-573.
State Health Department, Tamil Nadu. (2021). Diabetes Care Initiatives Annual Report. https://tnhealth.tn.gov.in
Tao, B., Pietropaolo, M., Atkinson, M., Schatz, D., & Taylor, D. (2010). Estimating the cost of type 1 diabetes in the U.S.: A propensity score matching method. PLOS ONE, 5(7), e11501. https://doi.org/10.1371/journal.pone.0011501
World Health Organization (WHO). (2021). Global report on diabetes. Geneva, Switzerland: WHO. https://www.who.int/publications/i/item/9789241565257
World Health Organization (WHO). (2021). Global Report on Diabetes.
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., ... & Ezzati, M. (2020). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet, 387(10027), 1513–1530. https://doi.org/10.1016/S0140-6736(16)00618-8
Downloads
Published
How to Cite
License
Copyright (c) 2024 Shikha Sharma, Dr. Amba Agarwal, Dr. Amandeep Kaur
This work is licensed under a Creative Commons Attribution 4.0 International License.
